Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 1 Pathogen-specific antibody levels in IVIG preparations

From: Antibody levels to tetanus, diphtheria, measles and varicella in patients with primary immunodeficiency undergoing intravenous immunoglobulin therapy: a prospective study

IVIG Mean IU/mL SD Number of lots
Tetanus 19,92 10,19 38
Immunoglobulin® 20,04 1,60 2
Endobulin® 9,25 1,45 3
Flebogamma® 26,02 10,64 6
Octagam® 18,99 7,91 16
Tegeline® 18,64 13,68 9
Vigam® 30,58 3,70 2
Diphtheria 10,97 9,58 38
Immunoglobulin® 12,87 6,97 2
Endobulin® 7,82 5,29 3
Flebogamma® 19,86 19,35 6
Octagam® 10,05 6,48 16
Tegeline® 7,75 4,11 9
Vigam® 8,98 5,41 2
Measles 28,53 18,53 38
Immunoglobulin® 43,15 41,56 2
Endobulin® 9,65 0,53 3
Flebogamma® 35,04 12,73 6
Octagam® 23,04 16,10 16
Tegeline® 39,06 18,76 9
Vigam® 19,04 6,98 2
Varicella 21,75 12,19 38
Immunoglobulin® 19,47 10,87 2
Endobulin® 11,06 7,88 3
Flebogamma® 32,26 11,30 6
Octagam® 21,60 13,28 16
Tegeline® 20,90 10,12 9
Vigam® 13,62 0,42 2
  1. The bold data represent the mean for all of the 38 different lots.